J&J | Passifs Courants



Current Liabilities Changement Date
AbbVie USD 38.75B 4.31B 2024-12
Abbott USD 14.16B 745M 2024-12
Amgen USD 23.1B 2.79B 2024-12
AstraZeneca USD 27.87B 1.94B 2024-12
Baxter International USD 6.51B 311M 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Becton, Dickinson and Co. USD 7.66B 1.29B 2024-12
Biogen USD 5.53B 103.8M 2024-12
Boston Scientific USD 6.4B 489M 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
CONMED USD 278.13M 4.18M 2024-12
Cooper Companies USD 999.6M 23.2M 2025-01
Dexcom USD 2.93B 1.2B 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 21.7B 238M 2024-12
Globus Medical USD 855.91M 37.85M 2024-12
Hologic USD 1B 34.8M 2024-12
Indivior 962M 50M 2024-09
Insulet USD 528.4M 22.2M 2024-12
Integra LifeSciences USD 922.13M 9.56M 2024-12
Intuitive Surgical USD 2.21B 536.8M 2024-12
J&J USD 50.32B 1.44B 2024-12
Medtronic USD 11.84B 355M 2025-01
Merck USD 28.42B 1.17B 2024-12
Merit Medical Systems USD 216.4M 15.32M 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 43B 216M 2024-12
Regeneron Pharmaceuticals USD 5.7B 2.04B 2024-12
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 30.03B 5.82B 2024-06
Stryker USD 7.62B 53M 2024-12
Tandem Diabetes Care USD 247.05M 12.23M 2024-12
Teva Pharmaceutical Industries USD 12.8B 1B 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12
Zoetis USD 3.41B 1.71B 2024-12



J&J Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.